[go: up one dir, main page]

SE0103749D0 - Treatment of congestive heart failure - Google Patents

Treatment of congestive heart failure

Info

Publication number
SE0103749D0
SE0103749D0 SE0103749A SE0103749A SE0103749D0 SE 0103749 D0 SE0103749 D0 SE 0103749D0 SE 0103749 A SE0103749 A SE 0103749A SE 0103749 A SE0103749 A SE 0103749A SE 0103749 D0 SE0103749 D0 SE 0103749D0
Authority
SE
Sweden
Prior art keywords
substance
treatment
heart failure
congestive heart
chf
Prior art date
Application number
SE0103749A
Other languages
English (en)
Inventor
Olle Isaksson
Joergen Isgaard
Gudmundur Johannsson
Original Assignee
Sahltech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sahltech Ab filed Critical Sahltech Ab
Priority to SE0103749A priority Critical patent/SE0103749D0/sv
Publication of SE0103749D0 publication Critical patent/SE0103749D0/sv
Priority to JP2003541869A priority patent/JP2005507949A/ja
Priority to PCT/SE2002/002048 priority patent/WO2003039578A1/en
Priority to EP02786312A priority patent/EP1450851A1/en
Priority to US10/494,328 priority patent/US20050009744A1/en
Priority to AU2002351560A priority patent/AU2002351560A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0103749A 2001-11-08 2001-11-08 Treatment of congestive heart failure SE0103749D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0103749A SE0103749D0 (sv) 2001-11-08 2001-11-08 Treatment of congestive heart failure
JP2003541869A JP2005507949A (ja) 2001-11-08 2002-11-08 うっ血性心不全の治療
PCT/SE2002/002048 WO2003039578A1 (en) 2001-11-08 2002-11-08 Treatment of congestive heart failure
EP02786312A EP1450851A1 (en) 2001-11-08 2002-11-08 Treatment of congestive heart failure
US10/494,328 US20050009744A1 (en) 2001-11-08 2002-11-08 Treatment of congestive heart failure
AU2002351560A AU2002351560A1 (en) 2001-11-08 2002-11-08 Treatment of congestive heart failure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0103749A SE0103749D0 (sv) 2001-11-08 2001-11-08 Treatment of congestive heart failure

Publications (1)

Publication Number Publication Date
SE0103749D0 true SE0103749D0 (sv) 2001-11-08

Family

ID=20285941

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0103749A SE0103749D0 (sv) 2001-11-08 2001-11-08 Treatment of congestive heart failure

Country Status (6)

Country Link
US (1) US20050009744A1 (sv)
EP (1) EP1450851A1 (sv)
JP (1) JP2005507949A (sv)
AU (1) AU2002351560A1 (sv)
SE (1) SE0103749D0 (sv)
WO (1) WO2003039578A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090053334A1 (en) * 2006-01-31 2009-02-26 Nat. Uni. Corp. Hokkaido University Ghrelin production promoter
WO2008111573A1 (ja) 2007-03-12 2008-09-18 Snow Brand Milk Products Co., Ltd. 成長ホルモン分泌促進剤
WO2011087102A1 (ja) * 2010-01-15 2011-07-21 国立大学法人宮崎大学 加療中動物の回復促進治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001113A (en) * 1987-10-14 1991-03-19 Merck & Co., Inc. Di- or tripeptide renin inhibitors containing lactam conformational restriction in ACHPA
US5760069A (en) * 1995-02-08 1998-06-02 Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 Method of treatment for decreasing mortality resulting from congestive heart failure

Also Published As

Publication number Publication date
WO2003039578A1 (en) 2003-05-15
EP1450851A1 (en) 2004-09-01
JP2005507949A (ja) 2005-03-24
WO2003039578A8 (en) 2005-03-17
AU2002351560A1 (en) 2003-05-19
US20050009744A1 (en) 2005-01-13

Similar Documents

Publication Publication Date Title
AU1079701A (en) Oral transmucosal drug dosage using solid solution
CA2436421A1 (en) Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
CA2302700A1 (en) New use for budesonide and formoterol
EA200401009A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
RU2002127804A (ru) Лекарственная система для лечения осложнений, связанных с диабетом, и невропатии, и их применения
SE0101379D0 (sv) Komposition som hämmar utsöndring av magsyra
NO20100569L (no) Farmasoytiske formuleringer og anvendelse derav i forebyggelsen av slag, diabetes og/eller kongestivt hjertesvikt
ATE493981T1 (de) Einmal tägliche dosierformen von trospium
NZ507203A (en) Use of dexmedetomidine for ICU sedation
MXPA02003495A (es) Derivados de piridinio para el manejo de complicaciones vasculares diabeticas y relacionadas con la edad, proceso para su preparacion, y usos terapeuticos de los mismos.
JP2002530353A5 (sv)
CA2356701A1 (en) Gene therapy for diabetic ischemic disease
SE0103749D0 (sv) Treatment of congestive heart failure
CA2450915A1 (en) Use of levosimendan and beta-adrenergic receptor antagonist for the treatment of heart failure
SE9301877D0 (sv) In situ gel for therapeutic use
SE9902597D0 (sv) New use
PT891186E (pt) Administração nasal de agentes para o tratamento de emese tardia
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
AR062894A1 (es) Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths)
ATE247462T1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
CA2403674A1 (en) The use of t3 for treating congestive heart failure
WO2005020968A3 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
JP2000119186A (ja) スクラルファート含有局所投与用医薬組成物